Biotechnology

Eisai to apply for Alzheimer's treatment approval in fiscal 2022

CEO Naito says trials go 'smoothly' and sees candidate as growth driver

September 23, 2020 02:45 JST

Compatriot CanSino also rushes for mass output as clinical trials continue

August 28, 2020 03:19 JST

Production will fulfill order from British government for 60m doses

August 18, 2020 01:53 JST

Diagnostic kits to help fill US testing gap

August 13, 2020 00:49 JST

South Korean company predicts long-term growth in contract drugmaking business

August 11, 2020 15:57 JST

Tokyo's second deal, after Pfizer agreement, diversifies early-stage supply

August 8, 2020 03:46 JST

Japanese group ties up with US biotech company for late-stage trial

July 25, 2020 01:43 JST

UK company expects to begin Japan tests in August

July 21, 2020 12:53 JST

Singapore tightens rules on travelers from Japan, Hong Kong

July 18, 2020 12:01 JST

Sovereign fund leads UK Glympse Bio's $46.7m fundraising

July 17, 2020 15:09 JST